Fialho; Arsenio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fialho; Arsenio.The latest application filed is for "compositions and methods for treating conditions related to ephrin signaling with cupredoxins".

Company Profile

3.22.17

Fialho; Arsenio - Lisbon PT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for treating conditions related to ephrin signaling with Cupredoxins Grant 10,889,621 - Chakrabarty , et al. January 12, 2	2021-01-12
Compositions for treating HIV infection with cupredoxin and cytochrome C Grant 10,266,868 - Chakrabarty , et al.	2019-04-23
Cupredoxin derived transport agents and methods of use thereof Grant 10,239,920 - Chakrabarty , et al.	2019-03-26
Compositions And Methods For Treating Conditions Related To Ephrin Signaling With Cupredoxins App 20180319847 - Chakrabarty; Ananda ; et al.	2018-11-08
Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof Grant 10,058,585 - Chaudhari , et al. August 28, 2	2018-08-28
Compositions and methods for treating conditions related to ephrin signaling with cupredoxins Grant 9,957,304 - Chakrabarty , et al. May 1, 2	2018-05-01
Compositions And Methods For Treating Conditions Related To Ephrin Signaling With Cupredoxins And Mutants Thereof App 20160151452 - Chaudhari; Anita ; et al.	2016-06-02
Cupredoxin Derived Transport Agents And Methods Of Use Thereof App 20160031947 - Chakrabarty; Ananda ; et al.	2016-02-04
Cupredoxin derived transport agents and methods of use thereof Grant 9,161,989 - Chakrabarty , et al. October 20, 2	2015-10-20
Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof Grant 9,096,663 - Chaudhari , et al. August 4, 2	2015-08-04
Cupredoxin Derived Transport Agents And Methods Of Use Thereof App 20140037554 - Chakrabarty; Ananda ; et al.	2014-02-06
Compositions and methods for treating malaria with cupredoxin and cytochrome Grant 8,623,816 - Chakrabarty , et al. January 7, 2	2014-01-07
Cupredoxin derived transport agents and methods of use thereof Grant 8,530,635 - Chakrabarty , et al. September 10, 2	2013-09-10
Cupredoxin Derived Transport Agents And Methods Of Use Thereof App 20130011338 - Chakrabarty; Ananda ; et al.	2013-01-10
Cupredoxin derived transport agents and methods of use thereof Grant 8,206,685 - Chakrabarty , et al. June 26, 2	2012-06-26
Compositions And Methods For Treating Hiv Infection With Cupredoxin And Cytochrome C App 20110070217 - CHAKRABARTY; ANANDA ; et al.	2011-03-24
Compositions And Methods To Prevent And/or Treat Cancer With Pa-card App 20100278937 - Das Gupta; Tapas K. ; et al.	2010-11-04
Compositions and methods for treating HIV infection with cupredoxin and cytochrome c Grant 7,795,410 - Chakrabarty , et al. September 14, 2	2010-09-14
Cupredoxin Derived Transport Agents And Methods Of Use Thereof App 20100209355 - Chakrabarty; Ananda ; et al.	2010-08-19
Compositions and methods for treating malaria with cupredoxin and cytochrome Grant 7,740,857 - Chakrabarty , et al. June 22, 2	2010-06-22
Cupredoxin derived transport agents and methods of use thereof Grant 7,691,383 - Chakrabarty , et al. April 6, 2	2010-04-06
Compositions And Methods For Treating Hiv Infection With Cupredoxin And Cytochrome C App 20090191623 - Chakrabarty; Ananda ; et al.	2009-07-30
Compositions and methods for treating HIV infection with cupredoxin and cytochrome c Grant 7,511,117 - Chakrabarty , et al. March 31, 2	2009-03-31
Compositions And Methods For Treating Malaria With Cupredoxin And Cytochrome App 20080293619 - Chakrabarty; Ananda ; et al.	2008-11-27
Compositions And Methods For Treating Malaria With Cupredoxin And Cytochrome App 20080287360 - CHAKRABARTY; Ananda ; et al.	2008-11-20
Compositions And Methods For Treating Conditions Related To Ephrin Signaling With Cupredoxins And Mutants Thereof App 20080221015 - Chaudhari; Anita ; et al.	2008-09-11
Compositions And Methods For Treating Hiv Infection With Cupredoxin And Cytochrome C App 20080131873 - Chakrabarty; Ananda ; et al.	2008-06-05
Compositions and methods for treating conditions related to ephrin signaling with cupredoxins Grant 7,381,701 - Chakrabarty , et al. June 3, 2	2008-06-03
Compositions And Methods For Treating Conditions Related To Ephrin Signaling With Cupredoxins App 20080089878 - Chakrabarty; Ananda ; et al.	2008-04-17
Compositions and methods for treating malaria with cupredoxin and cytochrome Grant 7,338,766 - Chakrabarty , et al. March 4, 2	2008-03-04
Compositions and methods for treating HIV infection with cupredoxin and cytochrome c Grant 7,301,010 - Chakrabarty , et al. November 27, 2	2007-11-27
Compositions and methods for treating malaria with cupredoxin and cytochrome App 20060251669 - Chakrabarty; Ananda ; et al.	2006-11-09
Compositions and methods for treating HIV infection with cupredoxin and cytochrame C App 20060251639 - Chakrabarty; Ananda ; et al.	2006-11-09
Cupredoxin derived transport agents and methods of use thereof App 20060149037 - Chakrabarty; Ananda ; et al.	2006-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.